Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC
Clinical trial NCT02982395 · TERMINATED
Trial details
- NCT number
- NCT02982395
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.